Likelihood of outsourcing drug development activities by biopharma companies 2023
According to a survey conducted in 2023, almost three quarters of surveyed biopharma executives stated that it is extremely likely or very likely that their company will outsource patient recruitment within the next two years. This statistic describes the likelihood of outsourcing select drug development activities among biopharmaceutical companies, within the next two years.
